Tebra (Kareo) AI Visibility Market Strategy Report - Medical Billing Services

Answer Capsule

Tebra (Kareo) holds the second-strongest recommendation position in the Medical Billing Services category, with 38.6% valid recommendation coverage in October 2026. The brand is visible in 58.4% of qualified AI observations and converts that presence into shortlist placements at a solid rate, but its rank-one recommendation rate fell significantly from 12.3% in July 2026 to 6.6% in October 2026. The clearest win is sustained top-three recommendation strength at 20.0%, second only to athenahealth. The clearest weakness is first-position erosion, where the brand lost roughly half its rank-one placements over the series. The clearest opportunity is recovering those first-position recommendations while the category's pricing and comparison prompt clusters remain unmeasured.

Who This Report Is For

This report is for Tebra (Kareo) marketing, product marketing, and revenue leadership teams evaluating how the brand appears in AI-generated recommendations for medical billing and RCM software, and for competitive strategists tracking recommendation-stage visibility across the category.

Report Card

Executive Summary

Tebra (Kareo) is the second-most-recommended brand in the Medical Billing Services category, with 38.6% valid recommendation coverage in October 2026. The brand appears in 58.4% of qualified AI observations, giving it strong raw mention presence, but its recommendation conversion rate trails the category leader by 15.7 percentage points. athenahealth leads at 54.3% coverage, and the gap has widened from 9.0 points in July 2026.

The brand's recommendation profile is positive on sentiment, with 266 positive mentions, 79 neutral mentions, and zero negative mentions across 345 present observations. Net sentiment stands at 0.771, indicating consistently favorable framing when the brand appears. No negative framing was detected in any platform or cluster.

Tebra (Kareo) holds the second-highest top-three recommendation rate in the category at 20.0%, behind athenahealth at 41.6% and ahead of AdvancedMD at 24.2%. This confirms the brand is regularly shortlisted in AI-generated recommendations. However, the brand's rank-one rate fell from 12.3% in July 2026 to 6.6% in October 2026, a significant decline that represents the loss of roughly half its first-position placements over the series.

The strongest platform signal for Tebra (Kareo) is Copilot, where the brand achieved a 45.3% valid recommendation coverage rate and a 17.2% rank-one rate, both above its overall averages. The brand also performs well on ChatGPT with 45.9% coverage. The weakest platform signal is Perplexity, where coverage drops to 31.9% and rank-one rate falls to 5.8%.

The clearest gap is in first-position recommendations. While Tebra (Kareo) maintains strong shortlist breadth, its ability to secure the top recommendation slot has eroded. AdvancedMD, despite lower overall coverage at 37.9%, achieved a rank-one rate of 5.9% in October 2026, nearly matching Tebra (Kareo)'s 6.6% and up significantly from 2.3% in July 2026. The cushion between Tebra (Kareo) and AdvancedMD narrowed to 0.7 percentage points in October 2026.

A high-severity factual inconsistency was detected across Gemini and Perplexity regarding Tebra (Kareo)'s corporate identity and brand relationships, which may affect how AI systems frame the brand in recommendation contexts.

What Tebra (Kareo) Is Winning

Questions This Section Answers

• Where does Tebra (Kareo) rank in Medical Billing Services recommendations compared to AdvancedMD and eClinicalWorks?
• Which AI platform produces the strongest recommendation signal for Tebra (Kareo)?

Tebra (Kareo) holds the second-strongest recommendation position in the Medical Billing Services category. The brand's 38.6% valid recommendation coverage places it ahead of AdvancedMD (37.9%), eClinicalWorks (27.8%), and all other tracked competitors except athenahealth.

The brand's top-three recommendation rate of 20.0% is the second-highest in the category. This indicates that when AI systems generate shortlist-style recommendations, Tebra (Kareo) appears in the top three positions approximately one in five times. This is a meaningful position in a category where most brands achieve top-three rates below 12%.

Tebra (Kareo) shows zero negative mentions across all 345 present observations. The brand's net sentiment score of 0.771 reflects consistently positive or neutral framing. This absence of negative framing is notable in a category where cautionary or comparison-anchor mentions can dilute recommendation strength.

The brand performs strongly on Copilot, achieving 45.3% valid recommendation coverage and a 17.2% rank-one rate on that platform. Copilot represents the brand's strongest platform-specific recommendation signal, with 29 valid recommendations from 45 present observations. Tebra (Kareo) also performs well on ChatGPT, where it achieves 45.9% coverage and 28 valid recommendations.

Where Tebra (Kareo) Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why has Tebra (Kareo)'s rank-one recommendation rate declined while AdvancedMD gained first-position ground?
• Which AI platform shows the weakest recommendation coverage for Tebra (Kareo)?
• What do the unmeasured pricing and comparison prompt clusters mean for interpreting Tebra (Kareo)'s recommendation performance?

The clearest gap for Tebra (Kareo) is first-position recommendation erosion. The brand's rank-one rate fell from 12.3% in July 2026 to 6.6% in October 2026, a significant decline. This means that while the brand remains visible and shortlisted, it is losing the top recommendation slot to competitors.

AdvancedMD has narrowed the gap. In July 2026, Tebra (Kareo) held a rank-one rate of 12.3% compared to AdvancedMD's 2.3%. By October 2026, Tebra (Kareo) had fallen to 6.6% while AdvancedMD had risen to 5.9%. The two brands are now nearly tied on first-position recommendations despite Tebra (Kareo) maintaining higher overall coverage.

The gap to athenahealth remains substantial and has widened. athenahealth leads with 54.3% valid recommendation coverage and an 18.1% rank-one rate. Tebra (Kareo) trails by 15.7 percentage points on coverage and 11.5 percentage points on rank-one rate. The leader's advantage grew from 9.0 points in July 2026 to 15.7 points in October 2026.

Perplexity represents the brand's weakest platform. Tebra (Kareo) achieves 31.9% valid recommendation coverage on Perplexity, below its overall average of 38.6%. The rank-one rate on Perplexity is 5.8%, also below the brand's overall rate. This suggests the brand's recommendation strength is not evenly distributed across AI platforms.

The category's pricing and comparison prompt clusters remain unmeasured in the public benchmark. All 591 qualified observations in October 2026 fell into the brand recommendation cluster. This means the benchmark cannot yet show how Tebra (Kareo) performs when buyers ask about pricing, value, or head-to-head comparisons, which are critical decision-stage prompts.

Biggest Opportunity

Questions This Section Answers

• What would it take for Tebra (Kareo) to recover first-position recommendations from competitors?
• Which platforms offer the clearest path to rebuilding rank-one strength?

The biggest opportunity for Tebra (Kareo) is recovering first-position recommendation strength. The brand lost roughly half its rank-one placements between July 2026 and October 2026, falling from 12.3% to 6.6%. Meanwhile, AdvancedMD gained first-position ground, rising from 2.3% to 5.9%.

Recovering rank-one recommendations would require understanding which prompts and platforms previously produced first-position placements for Tebra (Kareo) and which competitor now occupies that slot. The brand's strong performance on Copilot (17.2% rank-one rate) and ChatGPT (6.6% rank-one rate) suggests these platforms may offer the clearest path to rebuilding first-position strength.

The opportunity is specific: identify the prompt contexts where Tebra (Kareo) appears in the top three but not at rank one, and determine what evidence or framing would move the brand to the first position. This is a recommendation conversion opportunity rather than a visibility opportunity, since the brand already appears in 58.4% of qualified observations.

Competitive Landscape

Questions This Section Answers

• How do Tebra (Kareo)'s top-three and rank-one rates compare to athenahealth and AdvancedMD?
• Where does Tebra (Kareo) rank on average recommended position among Medical Billing Services brands?

athenahealth holds dominant recommendation-stage strength in the Medical Billing Services category, with Tebra (Kareo) as the strongest challenger. The two brands lead the category on valid recommendation coverage, top-three rate, and rank-one rate, though the gap between them widened over the four-month series.

Average recommended rank covers rank-eligible recommendations only.

Tebra (Kareo) ranks third on top-three rate and third on rank-one rate, behind athenahealth and AdvancedMD on both measures. The brand's average recommended rank of 3.25 places it fourth, behind athenahealth (2.21), R1 RCM (2.76), and AdvancedMD (2.98). The brand's sentiment score of 0.7710 is the second-highest among the top five brands by coverage.

AI Response Inconsistency Alerts

Questions This Section Answers

• What conflicting claims do Gemini and Perplexity make about Tebra (Kareo)'s corporate identity?
• Which source pages appear to be driving the AI confusion about Tebra (Kareo)'s brand relationships?

One high-severity factual inconsistency was detected for Tebra (Kareo), involving two AI platforms: Gemini and Perplexity. The conflict concerns the brand's corporate identity and ownership relationships.

When asked "What is the easiest medical billing software?", Gemini stated that "Kareo is branded as Tebra," citing sources including Digitalis Medical and TechRadar. Perplexity, responding to the same question, stated that "Tebra is in the CareCloud family," citing sources including Medesk, PracticeSuite, and CareCloud's own website. These claims are mutually incompatible, since Kareo/Tebra and CareCloud are separate companies.

The conflict was flagged with high confidence (0.9) and high severity. The flagged sources supporting the Gemini response include Digitalis Medical ("Kareo (Tebra): Best Overall") and Medesk ("Tebra (formerly Kareo): Quick Data Entry and Verification"). The Perplexity response appears to have drawn from a CareCloud-published page listing medical billing software, which may have created confusion about brand relationships.

This inconsistency matters because AI systems providing conflicting information about a brand's corporate identity can undermine buyer confidence and create confusion about product ownership, support, and roadmap. The conflict also suggests that some source pages in the public evidence layer may be conflating Tebra (Kareo) with other brands or misattributing corporate relationships.

Prompt Evidence

Gemini / Brand Recommendation Prompt: "What is the easiest medical billing software?" Result: Gemini recommended Tebra (Kareo) but described it as "branded as Tebra," citing sources that correctly identify the Kareo-to-Tebra rebrand.

Perplexity / Brand Recommendation Prompt: "What is the easiest medical billing software?" Result: Perplexity placed Tebra (Kareo) in the "CareCloud family," a factual error that conflicts with Gemini's response and with the brand's actual corporate structure.

Copilot / Brand Recommendation Prompt: "best medical billing software" Result: Tebra (Kareo) achieved strong recommendation placement on Copilot, with a 17.2% rank-one rate and 45.3% valid recommendation coverage on this platform.

ChatGPT / Brand Recommendation Prompt: "top medical billing software" Result: Tebra (Kareo) appeared in 45.9% of ChatGPT recommendations, with 28 valid recommendations from 43 present observations.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts, platforms, and competitor displacements where Tebra (Kareo) appears in the top three but not at rank one, and identify the evidence sources shaping those outcomes.

Phase 2: Recommendation Readiness Plan Prioritize the prompt clusters and platforms where first-position recovery is most achievable, focusing on Copilot and ChatGPT where the brand already performs strongly.

Phase 3: Owned Answer Layer Buildout Strengthen the brand's owned content to clearly establish corporate identity, product relationships, and differentiation, reducing the risk of AI systems conflating Tebra (Kareo) with other brands.

Phase 4: Citation / Authority Layer Development Address the source-layer inconsistencies identified in the AI response conflict data, particularly third-party pages that misattribute the brand's corporate relationships.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track rank-one rate recovery, top-three rate stability, and platform-specific recommendation performance to measure progress against the baseline.

Why This Matters

AI presence alone is not enough. Tebra (Kareo) appears in 58.4% of qualified AI observations, but converts that presence into valid recommendations at a lower rate than the category leader. The brand's rank-one rate decline shows that being mentioned and being recommended first are different outcomes, and the gap between them has commercial consequences.

The next move is targeted correction of the prompt, page, and citation layers. Recovering first-position recommendations requires understanding which prompts previously produced rank-one placements, which competitor now occupies that slot, and what evidence or framing would move Tebra (Kareo) back to the top. The brand's strong performance on Copilot and ChatGPT suggests these platforms offer the clearest path to rebuilding first-position strength.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Tebra (Kareo): (266 × 1 + 79 × 0 + 0 × -1) / 345 = 0.7710

This score matters because unclassified mention counts are misleading. A brand with 345 mentions could appear strong on raw visibility, but if those mentions are neutral references, cautionary comparisons, or competitor displacement contexts, the brand is not actually being recommended. Tebra (Kareo)'s sentiment score of 0.7710 indicates that the vast majority of its mentions are positive, with no negative framing detected.

Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it distinguishes between being mentioned and being recommended.

Sentiment by Platform

Questions This Section Answers

• Which platforms show the strongest recommendation sentiment for Tebra (Kareo) in Medical Billing Services?
• How does recommendation sentiment differ between Copilot and Perplexity?

Methodology

1. This report is a benchmark-based analysis of Tebra (Kareo)'s AI recommendation visibility in the Medical Billing Services category for October 2026.
2. The reporting window covers October 2026, with trend comparisons to July 2026, August 2026, and September 2026.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The benchmark collected 800 prompt-surface observations in October 2026, producing 591 qualified observations after qualification stages.
5. The competitor universe includes 10 tracked brands: athenahealth, Tebra (Kareo), AdvancedMD, eClinicalWorks, DrChrono, CareCloud, R1 RCM, CureMD, Greenway Health, and Medusind.
6. One public high-intent cluster qualified for analysis: Brand Recommendation (C01). Two additional clusters (Comparison & Alternatives, Pricing & Cost) were defined but contained no qualified observations.
7. Stage 0 extraction retained query, AI surface, answer, brand outcome, recommendation placement, sentiment, and citations where exposed.
8. A mention is defined as any appearance of the brand in an AI-generated response, regardless of recommendation status.
9. A valid recommendation is defined as an explicit recommendation or shortlist inclusion, excluding neutral references, cautionary mentions, or comparison-anchor placements.
10. The public benchmark does not measure market share, attributable sales, organic-search ranking, social mention volume, or private channels.
11. Small-count brands carry higher uncertainty; their movements are directional signals, not conclusive trends.
12. Source presence is evidence about the information environment and is not automatically proof that the source caused the recommendation.

See How AI Is Recommending Your Brand

The public benchmark shows where Tebra (Kareo) stands in AI-generated recommendations across the Medical Billing Services category. A company-level AI visibility audit can show why the brand appears where it does, which prompts and platforms drive first-position recommendations, and which competitor takes the top slot when Tebra (Kareo) is displaced. The audit maps prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized visibility strategy.